Calls for action to improve outcomes for rare cancer patients

Less than half of Australians diagnosed with rare cancers survive five years after diagnosis, with advocates calling on the government to step in to improve outcomes. The Rare Cancer Moonshot report found the five-year survival rate is just 45% of people with rare cancers, compared to 77% for common cancers. Advocates are calling on the government, healthcare, research groups and the community to improve outcomes for 56,000 patients each year.